Physician profile
Jonathan W Wallace
NPI 1568422012
$216,925.54
in general payments reported to CMS, 2019-2025
42 companies · $996 in 2025
The $996 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,546 · 2020: $39K · 2021: $108K · 2022: $36K · 2023: $19K · 2024: $9,134 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Food and Beverage: $3,543 · Travel and Lodging: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,000.00 |
| Food and Beverage | $3,543.34 |
| Travel and Lodging | $1,928.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $211,004.95 | 2019-2025 | Da Vinci Surgical System |
| Northgate Technologies, INC. | $800.00 | 2021 | |
| Covidien LP | $541.03 | 2019-2020 | |
| Novo Nordisk INC | $468.72 | 2020-2025 | Wegovy |
| Medtronic, INC. | $377.44 | 2021-2024 | Signia, Progrip |
| Smith+Nephew, INC. | $350.71 | 2019-2025 | Stravix |
| Teleflex LLC | $345.02 | 2025 | Titan Sgs Bailout Chuck |
| Apollo Endosurgery US INC | $342.62 | 2019 | |
| Organogenesis INC. | $245.02 | 2021 | |
| Kerecis Limited | $232.14 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Angiodynamics, INC. | $177.63 | 2019-2020 | |
| Endogastric Solutions, INC | $161.78 | 2021-2024 | Esophyx |
| Pacira Pharmaceuticals Incorporated | $144.91 | 2023-2025 | Exparel |
| Hologic Sales and Service, LLC | $138.40 | 2024 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $131.65 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $123.93 | 2024-2025 | Gore Synecor Biomaterial |
| Ethicon US, LLC | $111.34 | 2019-2025 | Vicryl, Echelon Circular, Echelon Flex |
| Stryker Corporation | $110.06 | 2019 | |
| Baxter Healthcare | $105.26 | 2024 | Perclot |
| Integra Lifesciences Corporation | $94.77 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Takeda Pharmaceuticals U.S.A., INC. | $92.45 | 2022-2024 | Gattex |
| Tela Bio, INC. | $87.76 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Acera Surgical, INC. | $84.31 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $65.85 | 2024-2025 | |
| Bard Access Systems, INC. | $62.87 | 2019 | |
| Braintree Laboratories, INC. | $51.06 | 2019 | |
| Palette Life Sciences, INC. | $48.57 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $44.24 | 2022-2023 | Nascobal |
| Olympus America INC. | $43.49 | 2025 | Visera Elite Video System Center, Evis Exera III Colonovideoscope, Gastrointestinal Videoscope |
| Kci USA, INC. | $42.80 | 2021 | |
| Urgo Medical North America, LLC | $42.36 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Davol INC. | $40.26 | 2021-2022 | |
| Conmed Corporation | $32.26 | 2024 | Airseal |
| Solventum Corporation | $31.68 | 2024 | Activ.A.C. |
| Boston Scientific Corporation | $26.19 | 2023 | Spyglass Discover |
| Innovation Technologies INC | $22.61 | 2022 | |
| Tei Biosciences INC | $22.38 | 2019 | |
| Mimedx Group, INC. | $19.22 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.81 | 2022 | |
| Mesh Suture INC | $16.62 | 2024 | |
| Sanara Medtech INC. | $14.25 | 2024 | Celleraterx |
| Distalmotion US | $10.12 | 2025 | Dexter L6 Robot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.